Latest Lead News

Mad Paws Holdings has secured Foreign Investment Review Board approval for Rover Group’s full acquisition scheme, with the board unanimously recommending shareholder support.

Alligator Energy strengthens its executive team with key appointments as it shifts from exploration to uranium production, closing its Brisbane office and centralising operations in Adelaide.

Tolu Minerals announces a leadership change with Dr Chris Muller stepping in as CEO to guide the company through a pivotal phase of exploration and production at the Tolukuma Gold Mine.

Nyrada Inc. has released compelling preclinical data showing its drug candidate Xolatryp protects mitochondrial function by reducing calcium overload in brain injury models, bolstering confidence ahead of its Phase IIa trial in acute myocardial infarction.

OzAurum Resources has regained full control of the Mulgabbie North Gold Project feasibility study, initiating inhouse metallurgical testing that has already surpassed industry benchmarks, setting a strong technical foundation for potential gold production.

Paladin Energy Ltd has launched a significant A$300 million underwritten equity raising to advance its Patterson Lake South uranium project and support the ramp-up of its Langer Heinrich Mine, reinforcing its position in the global uranium market.

Brightstar Resources reports underground mining operations at its Laverton Hub are significantly ahead of schedule, targeting a +50% quarter-on-quarter production increase in the September quarter. The Fish Mine has turned cash flow positive, underpinning a robust growth outlook.

Xstate Resources has completed well pad construction for its Diona-1 well in Queensland’s Surat-Bowen Basin and is poised to begin drilling with a 51% interest in ATP 2077.

Medallion Metals has taken a crucial step forward by ordering a secondary ball mill to upgrade the Cosmic Boy Concentrator, underpinning its Sulphide Production Strategy and advancing its feasibility study toward a final investment decision.

Race Oncology has uncovered that its anticancer drug bisantrene exists as three light-sensitive isomers, with only one showing potent activity. The company has filed patents to protect this active form, potentially extending its intellectual property rights until 2045.

Paladin Energy has launched a fully underwritten A$300 million equity raising to advance its Patterson Lake South uranium project, aiming for a Final Investment Decision and first production by 2031.

Lincoln Minerals has expanded its exploration footprint at the Minbrie Copper-Base Metals Project, identifying two new drill-ready targets and confirming a large-scale multi-metal sulphide system stretching over 7km. Fully funded for drilling, the company aims to unlock significant growth potential in South Australia’s Eyre Peninsula.